Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-13Clinical Trial Update: Safety and Efficiency of γδ T Cell Against Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and efficacy of γδ T cells for breast cancer completed.
-
CLINICAL_TRIALS trial_result · 2020-07-13Clinical Trial Update: Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC) [Phase 1, Phase 2]
A phase 1/2 trial evaluating eribulin mesylate with PEGPH20 versus eribulin alone in HER2-negative, high-hyaluronan metastatic breast cancer…
-
CLINICAL_TRIALS trial_result · 2020-07-08Clinical Trial Update: A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients [Phase 1]
Phase 1 pharmacokinetic study of Oraxol in breast cancer patients has been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-08Clinical Trial Update: Phase Ⅱ Study of Pegylated Liposomal Doxorubicin（PLD）Plus Trastuzumab in HER-2 Positive Metastatic Breast Cancer [Phase 2]
Phase II study evaluating pegylated liposomal doxorubicin plus trastuzumab in HER2-positive metastatic breast cancer is ongoing with status …
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating safety and efficacy of durvalumab plus paclitaxel in metastatic triple-negative breast cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway [Phase 2]
Phase II, single-arm trial of poziotinib as salvage treatment for metastatic breast cancer with HER2/EGFR mutation or activated AR/EGFR path…
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF [Phase 4]
Phase 4 randomized trial comparing fixed versus titrated letrozole regimens in breast cancer patients undergoing IVF; study completed with p…
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors [Phase 2]
A Phase 2 clinical trial evaluating neoadjuvant response-guided treatment for slowly proliferating hormone receptor positive breast tumors.
-
CLINICAL_TRIALS research · 2020-07-07Clinical Trial Update: Implementing Systematic Distress Screening in Breast Cancer
A completed clinical trial evaluating systematic distress screening in breast cancer patients with results posted in 2020.
-
FDA approval · 2020-07-06FDA Approved: KISQALI FEMARA CO-PACK — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for a Kisqali-Femara co-pack, combining ribociclib and letrozole in a single co-pack managed by Nova…
-
FDA approval · 2020-06-29FDA Approved: PHESGO — Original Application (Genentech, Inc.)
FDA approved PHESGO (PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF) from Genentech under an Original Application; a fixed-dose subcutaneou…
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer [Phase 3]
A Phase 3 study assessing the pharmacokinetics, efficacy, and safety of subcutaneous fixed-dose combination of pertuzumab and trastuzumab wi…
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: European Celecoxib Trial in Primary Breast Cancer [Phase 3]
Phase 3 clinical trial update of celecoxib in primary breast cancer completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 trial of Lucitanib (VEGFR-FGFR-PDGFR inhibitor) in metastatic breast cancer was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-22Clinical Trial Update: A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab [Phase 1]
Phase 1 study evaluating MEDI4736 (durvalumab) in combination with tremelimumab has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-19Clinical Trial Update: Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy [Phase 2]
Phase 2 trial update evaluating fatty acid synthase inhibition to enhance neoadjuvant chemotherapy in breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-06-19Clinical Trial Update: Exemestane-RAD001-Metformin [Phase 2]
Phase 2 clinical trial of exemestane with RAD001 and metformin for breast cancer was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-18Clinical Trial Update: Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor [Phase 3]
Phase III study evaluating BKM120 (buparlisib) or placebo with fulvestrant in postmenopausal women with hormone receptor–positive, HER2-nega…
-
CLINICAL_TRIALS trial_result · 2020-06-18Clinical Trial Update: Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer. (PHOEBE) [Phase 3]
Phase 3 trial comparing pyrotinib plus capecitabine to lapatinib plus capecitabine in HER2-positive metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Regional Anesthesia and Breast Cancer Recurrence [Phase 3]
Phase 3 clinical trial updating regional anesthesia impact on breast cancer recurrence has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib [Phase 2]
Phase 2 trial update evaluating pazopanib to reverse hormone resistance in advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy [Phase 4]
Phase 4 clinical trial evaluating the cardioprotective effect of L-carnitine and silymarin in patients receiving anthracycline chemotherapy …
-
CLINICAL_TRIALS trial_result · 2020-06-12Clinical Trial Update: Multi-4SCAR-T Therapy Targeting Breast Cancer [Phase 1, Phase 2]
A clinical trial update for a multi-4SCAR-T therapy targeting breast cancer in Phase 1 and Phase 2 stages.
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: A Multi-Reader Multi-Case Pivotal Trial
A multi-reader multi-case pivotal trial for a product in breast cancer has completed and results were posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer. [Phase 2, Phase 3]
Clinical trial update on neoadjuvant chemotherapy with or without metformin in early breast cancer (Phase 2 and Phase 3).